Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. doi: 10.1164/rccm.201204-0693OC. Epub 2012 Jul 12.
Long-term survival after lung transplantation is limited by infectious complications and by bronchiolitis obliterans syndrome (BOS), a form of chronic rejection linked in part to microbial triggers.
To define microbial populations in the respiratory tract of transplant patients comprehensively using unbiased high-density sequencing.
Lung was sampled by bronchoalveolar lavage (BAL) and upper respiratory tract by oropharyngeal wash (OW). Bacterial 16S rDNA and fungal internal transcribed spacer sequencing was used to profile organisms present. Outlier analysis plots defining taxa enriched in lung relative to OW were used to identify bacteria enriched in lung against a background of oropharyngeal carryover.
Lung transplant recipients had higher bacterial burden in BAL than control subjects, frequent appearance of dominant organisms, greater distance between communities in BAL and OW indicating more distinct populations, and decreased respiratory tract microbial richness and diversity. Fungal populations were typically dominated by Candida in both sites or by Aspergillus in BAL but not OW. 16S outlier analysis identified lung-enriched taxa indicating bacteria replicating in the lower respiratory tract. In some cases this confirmed respiratory cultures but in others revealed enrichment by anaerobic organisms or mixed outgrowth of upper respiratory flora and provided quantitative data on relative abundances of bacteria found by culture.
Respiratory tract microbial communities in lung transplant recipients differ in structure and composition from healthy subjects. Outlier analysis can identify specific bacteria replicating in lung. These findings provide novel approaches to address the relationship between microbial communities and transplant outcome and aid in assessing lung infections.
肺移植后的长期存活率受到感染并发症和闭塞性细支气管炎综合征(BOS)的限制,BOS 是一种部分与微生物触发因素相关的慢性排斥形式。
使用无偏高密度测序全面定义移植患者呼吸道中的微生物群。
通过支气管肺泡灌洗(BAL)和口咽冲洗(OW)对肺进行采样。使用细菌 16S rDNA 和真菌内部转录间隔区测序来分析存在的生物体。用于定义在肺相对于 OW 中富集的分类群的异常值分析图用于识别在口咽携带物背景下富集在肺中的细菌。
与对照组相比,肺移植受者 BAL 中的细菌负担更高,常见优势生物的出现,BAL 和 OW 之间群落之间的距离更大,表明种群更具独特性,以及呼吸道微生物丰富度和多样性降低。真菌种群通常在两个部位均由 Candida 主导,或在 BAL 中由 Aspergillus 主导,但在 OW 中则没有。16S 异常值分析确定了在肺部富集的分类群,表明细菌在下呼吸道中复制。在某些情况下,这证实了呼吸道培养物,但在其他情况下,它揭示了厌氧生物的富集或上呼吸道菌群的混合生长,并提供了通过培养发现的细菌相对丰度的定量数据。
肺移植受者的呼吸道微生物群落在结构和组成上与健康受试者不同。异常值分析可以识别在肺部复制的特定细菌。这些发现为解决微生物群落与移植结果之间的关系提供了新的方法,并有助于评估肺部感染。